The Commission organises the first of a series of 15 workshops under the Better Training for Safer Food (BTSF) programme on the prevention and control of AMR. The three-day practical training sessions target officials from the public health, veterinary and food producing sectors in all 28 EU countries.
15 November 2017 marks the 10th European Antibiotic Awareness Day, an EU-level initiative to raise awareness about the threat to public health of antimicrobial resistance (AMR) and the importance of using antibiotics prudently.
The Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) has published a Scientific Advice on (1) new scientific information on the safety of PIP breast implants and (2) another on the possible association between breast implants and anaplastic large cell lymphoma (ALCL).
Editorial by Françoise Grossetête, Member of the European Parliament and Former Rapporteur on the Directive on Cross-border Healthcare
Today, the Commission presented a report Parliament and the Council, on progress made in children's medicines since the Paediatric Regulation came into force 10 years ago.
Today in Brussels, the Steering Group on Promotion and Prevention meets for the third time to discuss best practices to support national policies on non-communicable diseases.
Today the Commission services and the European Medical Agency (EMA) have launched a joint action plan to foster the development of advanced therapy medicinal products (ATMPs), with the aim of streamlining the procedures and better addressing the specific requirements of ATMPs developers.
The Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) - Commission's independent Scientific Committee - published its final Opinion on tolerable intake of aluminium in order to determine the acceptable levels of aluminium counts in toys.
Message from Vytenis Andriukaitis, European Commissioner for Health and Food Safety
The Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) addresses existing gaps in the prevention of HIV and other co-infections, especially tuberculosis and viral hepatitis, among people who inject drugs. The 3rd partnership forum will take place on 26 and 27 October 2017.